MD Becker Partners LLC

1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville

1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters

10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal

10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters

8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville

8/22/2011 – “With Dendreon Humbled, Lessons Learned For Cancer Vaccine Makers” by Emily Hayes of The Pink Sheet

8/17/2011 – “Daiichi Sankyo is poster company for sector ripe for M&A” by David Holley of The Deal Pipeline

8/4/2011 – “Dendreon plunges as Provenge prospects wither” by by Bill Berkrot of Reuters

8/4/2011 – “Dendreon’s Stock Plunges on Low Provenge Sales” by Brett Chase of Minyanville

February 2, 2012 – MD Becker Partners is proud to return as “PR Sponsor” for the 19th Annual BioNJ Meeting, Awards Program and Networking Event being held at the Hilton East Brunswick. Click here to view the video clip our firm produced with highlights from the past several years.

November 10, 2011 – “MD Becker Partners Celebrates Third Successful Year in Business” press release

October 6, 2011 – MD Becker Partners hosted its 2nd annual “Cancer Immunotherapy: A Long Awaited Reality” conference event in New York.  For more information, please Click Here for the Event Website and for select video replays, visit the firm’s YouTube channel by clicking here.

June 30, 2011 – “Expert Roundtable Explores Recent Advances in Cancer Immunotherapy; Cancer Research Institute and MD Becker Partners Jointly Publish New Industry Report” press release

March 17-19, 2011 – MD Becker Partners participated in the Cancer Immunotherapy Consortium’s 2011 Scientific Colloquium, which took place in National Harbor, MD

12/19/2011 – “Agenus and ChemRar Enter Into Agreement in the Area of Personalized Cancer Vaccines” press release

12/12/2011 – “Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML” press release

11/15/2011 – “Bavarian Nordic Initiates Pivotal Phase 3 Trial of PROSTVAC® Prostate Cancer Immunotherapy” press release

10/18/2011 – “Positive Results Shown With Agenus’ QS-21 Stimulon(R) Adjuvant in Phase 3 Trial of GlaxoSmithKline’s Malaria Vaccine” press release

9/26/2011 – “Clinical Data Published in Vaccine Demonstrate Robust Immune Response With Agenus’ Herpes Vaccine Containing QS-21 Adjuvant” press release

8/18/2011 – “Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program” press release